
Best practice methods for the tech transfer of CGTs can increase process and analytics robustness while remaining scalable.
Larry Bellot, PhD, is scientific advisor, Cell and Gene Therapy, at Charles River Laboratories.

Published: December 6th 2023 | Updated:

Published: November 2nd 2023 | Updated: